CanBas Co Ltd (4575)

Currency in JPY
757.0
+18.0(+2.44%)
Closed·

CanBas Co Ltd Company Profile

CanBas Co., Ltd., a clinical stage biopharmaceutical company, engages in the basic research and clinical development of anti-cancer drugs. It develops CBP501, a compound which regulates the regulatory function of the protein calmodulin in Phase 2 clinical trials targeting non-small cell lung cancer; and CBS9106 for patients with advanced solid tumors. CanBas Co., Ltd. was incorporated in 2000 and is based in Numazu, Japan.

Employees
14
Market
Japan

Contact Information

Address
2-2-1, Otemachi, Numazu, 410-0801, Japan
Phone
81 55 954 3666
Fax
81 55 954 3668

Top Executives

Name
Title
Since
Age
Takumi KawabeCo-Founder, CEO, President & Representative Director200368
Makoto KatozumiCFO, GM of Corporate Planning Office & Director200962
Kazuyoshi SakamotoGM of Administration & Director202063
Daniel Douglas Von HoffChairman of Scientific Advisory Board-78
Yasuyuki KomiyamaIndependent Outside Director201667
Toshio FurutaIndependent Outside Director201664
Akira ShirakawaIndependent Outside Director201671
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.